Getting new auth cookie, if you see this message a lot, tell someone!

Index by author

October 01, 2015; Volume 82,Issue 10

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Jacob, Miriam S.
1. You have access
  A new class of drugs for systolic heart failure: The PARADIGM-HF study
  Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
  
  Cleveland Clinic Journal of Medicine October 2015, 82 (10) 693-701; DOI: https://doi.org/10.3949/ccjm.82a.14163
  
  Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.
Jaffer, Amir K.
1. You have access
  In Reply: Resuming anticoagulation after hemorrhage (April 2015)
  Alison Colantino, MD, Amir K. Jaffer, MD, MBA and Daniel J. Brotman, MD
  
  Cleveland Clinic Journal of Medicine October 2015, 82 (10) 640; DOI: https://doi.org/10.3949/ccjm.82c.10004
  
  Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).
Jandali, Mohamad Badr
1. You have access
  Resuming anticoagulation after hemorrhage (April 2015)
  Mohamad Badr Jandali, MD
  
  Cleveland Clinic Journal of Medicine October 2015, 82 (10) 639-640; DOI: https://doi.org/10.3949/ccjm.82c.10003
  
  Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).